Phase 3 Lymphoma Trial, Recruiting NCT06522555 Sponsor: Ruijin Hospital Condition: Lymphoma
Back to Lymphoma

Phase 3 Lymphoma Trial, Recruiting

NCT06522555
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) that has not spread to the brain or spinal cord, confirmed by a tissue test
  • You are aged 80 or older, OR you are aged 70–79 and have been assessed by doctors as "unfit" or "frail" based on a detailed health assessment
  • Your lymphoma has been given a risk score (called the International Prognostic Index) of between 2 and 5
  • You have at least one area of disease that is large enough to be measured on a scan (confirm with trial site for exact size requirements)
  • You are able to swallow capsules
  • Doctors estimate you are expected to live for at least 3 more months
  • You have not previously received any drug treatment for lymphoma (steroid medications are an exception)
  • You or your legal representative are willing and able to sign a consent form before the study begins

Who may not be able to join:

  • You have uncontrolled blood clotting problems, connective tissue diseases, serious ongoing infections, or certain other serious illnesses
  • Your blood test results at the screening stage show that certain levels — such as white blood cells, platelets, liver enzymes, or kidney function — are outside the required ranges (unless those results are caused by the lymphoma itself) (confirm with trial site for specific values)
  • You have serious or uncontrolled heart problems, including weak heart pumping function, certain heart muscle diseases, abnormal heart rhythms, or specific types of heart block (confirm with trial site for details)
  • You have hepatitis B virus (HBV) and your HBV viral levels are too high — specific testing is required depending on your hepatitis B test results (confirm with trial site)
  • You have a psychiatric (mental health) condition, or doctors believe you may not be able to follow the study's requirements
  • You are living with HIV
  • You have had a stroke or bleeding in the brain within the past 6 months
  • You have another medical condition that the research team believes could affect the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +862164370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Registry
ClinicalTrials.gov
Start date
29 July 2024
Est. completion
10 August 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

2-year PFS rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov